Trial
NCT03248492
A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Daiichi Sankyo
Collaborators
AstraZeneca; Daiichi Sankyo Co., Ltd.
Condition
Breast Cancer
Intervention
DS-8201a
Why stopped
The last participant was transitioned to alternative study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-26